[HTML][HTML] Elucidating novel hepatitis C virus–host interactions using combined mass spectrometry and functional genomics approaches
MA Germain, L Chatel-Chaix, B Gagne… - Molecular & Cellular …, 2014 - ASBMB
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
[PDF][PDF] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches*□ S
MA Germain, L Chatel-Chaix, B Gagne, E Bonneil… - 2014 - researchgate.net
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
[PDF][PDF] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches*□ S
MA Germain, L Chatel-Chaix, B Gagne, E Bonneil… - 2014 - Citeseer
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.
MA Germain, L Chatel-Chaix, B Gagné… - Molecular & Cellular …, 2013 - europepmc.org
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
[PDF][PDF] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches*□ S
MA Germain, L Chatel-Chaix, B Gagne, E Bonneil… - 2014 - enyopharma.com
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
[HTML][HTML] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches
MA Germain, L Chatel-Chaix, B Gagné… - Molecular & Cellular …, 2014 - Elsevier
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
[引用][C] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches
MA Germain, L Chatel-Chaix, B Gagné… - Molecular & Cellular …, 2014 - cir.nii.ac.jp
Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry
and Functional Genomics Approaches | CiNii Research CiNii 国立情報学研究所 学術情報 …
and Functional Genomics Approaches | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML][HTML] Elucidating Novel Hepatitis C Virus–Host Interactions Using Combined Mass Spectrometry and Functional Genomics Approaches
MA Germain, L Chatel-Chaix, B Gagné… - Molecular & Cellular …, 2014 - ncbi.nlm.nih.gov
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches
MA Germain, L Chatel-Chaix… - Molecular & …, 2014 - pubmed.ncbi.nlm.nih.gov
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
Elucidating novel hepatitis C virus-host interactions using combined mass spectrometry and functional genomics approaches.
MA Germain, L Chatel-Chaix, B Gagné… - Molecular & Cellular …, 2013 - europepmc.org
More than 170 million people worldwide are infected with the hepatitis C virus (HCV), for
which future therapies are expected to rely upon a combination of oral antivirals. For a …
which future therapies are expected to rely upon a combination of oral antivirals. For a …
